Author: WTN News

James Carlini could not be more unimpressed with Project Lightspeed, an AT&T broadband initiative that offers nothing out of the ordinary in terms of speed. In fact, most broadband systems with copper connections just don't have enough "giddy up," he writes in this edition of...

A Wisconsin biotechnology company is seeking to commercialize medicines to treat the diseases of aging, and it has adopted a business model that seeks to shoot down one degenerative disease at a time - perhaps before stem cell research gets a chance to. ...

Demo Letter columnist Chris Shipley took it on the chin this week following her recent column on the lack of user friendliness of a certain mobile device (which she refused to call a phone). While Shipley conceded one reader's point (about phoning and driving), she...

Professors from the Chippewa Valley Technical College, the University of Wisconsin-Eau Claire, and the University of Wisconsin-Stout are collaborating to develop curriculum for nanotechnology courses offered at Chippewa Valley Technical College. The National Science Foundation has contributed a $217,795 grant to the project, which will...

The ball is now in NASDAQ's court after Merge Healthcare filed its 2005 and first quarter 2006 financial reports before the stock market's opening bell on Aug. 30. But will the company's request for an extension to file its second quarter 2006 reports be the...

Another election cycle is upon us, and when the critics of the University of Wisconsin take aim during this fall's elections, voters would do well to remind themselves of all the university contributes to Wisconsin and its economy, writes Inside Wisconsin columnist Tom Still. Yes,...

After six years as a teacher and a collaborator in the field of nanotechnology at the University of Wisconsin-Madison, associate professor Rob Carpick is leaving. He cites discriminatory state laws prohibiting domestic partner benefits, but how much will such policies impact the state's ability to...

Michael Rosen breaks down Tom Friedman, and then explains what it all means to the American biotechnology industry in this presention of Yer Biotech Blues. In Rosen's view, the trend lines suggest that U.S. biotechs have some mighty challenges and opportunities ahead, particularly labor shortages...

With the University of Wisconsin-Madison as a proving ground, a group of college students has developed an online business model, and American college students are the target market. If they are successful in driving users to the site, their goal is to eliminate transaction fees...

Mithridion, Inc., a Madison-based biopharmaceutical start-up, is moving into the next phase of drug research and development with $296,800 in federal grants. One grant, which is designed to promote technology transfer, will enable collaboration between the company and University of Wisconsin-Madison researcher Jeffrey Johnson....